Literature DB >> 6804247

Allotypes in Basilea rabbits.

S Weiss, I Garcia, J C Jaton, A S Kelus.   

Abstract

Basilea rabbits produce immunoglobulin molecules, practically all of which have lambda light chains rather than kappa chains. This variant strain was derived form a homozygous (b9/b9) male. Sensitive serological methods revealed that at least some homozygous bas/bas individuals possess traces (about 100 ng/ml) of b9 molecules. This level usually increases to almost 1 microgram/ml upon hyperimmunization with pneumococcal or streptococcal vaccines. One exceptional rabbit, with 50 micrograms/ml of b9 molecules, was found. In spite of the presence of b9 molecules in early pre-immune bleeds, homozygous bas/bas rabbits produce strong anti-b9 antibodies; i.e., they are capable of making autoantibodies. These anti-b9 allotypic antisera were not distinguishable by our methods from routinely produced anti-b9.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6804247     DOI: 10.1002/eji.1830120213

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  4 in total

1.  Kappa-chain allotypes and isotypes in the rabbit: cDNA sequences of clones encoding b9 suggest an evolutionary pathway and possible role of the interdomain disulfide bond in quantitative allotype expression.

Authors:  N McCartney-Francis; R M Skurla; R G Mage; K E Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

2.  Genetics and expression of kappa-type light chains in Basilea rabbits.

Authors:  R G Mage; G O Young-Cooper; C B Alexander; A S Kelus
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

3.  Lack of K1b9 light chains in Basilea rabbits is probably due to a mutation in an acceptor site for mRNA splicing.

Authors:  E Lamoyi; R G Mage
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

4.  Sequence of a cDNA encoding Basilea kappa light chains (K2 isotype) suggests a possible relationship of protein structure to limited expression.

Authors:  K E Bernstein; E Lamoyi; N McCartney-Francis; R G Mage
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.